(Amherst, NH) – As drug developers endeavor to differentiate their products in the age of direct-to-consumer marketing, delivery technologies, once viewed as specialty or niche routes of administration are gaining more attention, particularly with regard to their perceived value in addressing the needs of specific patient populations. Because it relies on passive diffusion to effect drug transport, delivering drugs across mucosal membranes is attracting attention as a method that is well-suited to the preferences and limitations of important and growing patient segments – a group that includes pediatric patients, the elderly and mentally challenged patients – that may have difficulty taking medication in tablet or capsule form, or self-injecting parenteral formulations.
Delivering drugs across the mucosa, often referred to as transmucosal delivery, is really a family of administration methods that includes buccal tablets and films, oral sprays, sublingual films and wafers, suppositories and vaginal creams, that offer a number of attractive benefits that have led to increased activity among developers seeking to position their drug candidates as safe for self-administration and patient-friendly. Potential benefits include less-frequent dosing and avoidance of the effects of first pass metabolism.
A new report that presents a comprehensive assessment of the current status of oral transmucosal drug products and the prospects for late-stage development candidates has just been published. The report – Buccal Drug Delivery: Evolving Technology, Expanding Opportunities – contains insightful analysis of oral mucosal delivery technology and products, assessments of pipeline drugs, profiles of market participants, industry data and forecasts, and detailed analysis of regulatory and market factors.
More information is available at www.greystoneassociates.org .
About Greystone
Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Contact:
Mark Smith
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org
Source: Greystone Associates
